Department of Dermatology

Adjuvant melanoma treatment: real-world data from the DACH region (2021) Schumann K, Mangana J, Dummer R, Sindrilaru M, Reinhardt L, Meier F, Gutzmer R, et al. Conference contribution Development of combination therapy to delay resistance in BRAF-inhibitor treated melanoma (2021) Seretis A, Cappellano G, Bellmann L, Hornsteiner F, Tripp CH, Ortner-Tobider D, Mullins DW, et al. Conference contribution Preclinical evaluation of a combination of checkpoint blockade and dendritic cell vaccination against Merkel cell carcinoma (2021) Sauerer T, Gerer K, Hoyer S, Erdmann M, Berking C, Voll R, Schuler-Thurner B, et al. Conference contribution Brn3a expression is epigenetically controlled by HDAC2 in melanocytes and melanoma (2021) Heppt M, Wessely A, Hornig E, Kammerbauer C, Graf S, Besch R, French LE, et al. Conference contribution BRAF and MEK inhibitors affect dendritic cell maturation and T cell stimulation (2021) Hoyer S, Eberlein V, Schuler G, Berking C, Heinzerling L, Schaft N, Dörrie J Conference contribution Inhibiting the neural crest transcription factor SOX10 leads to cell cycle arrest and apoptosis in uveal melanoma cells (2021) Wessely A, Kammerbauer C, Lischer C, Vera González J, Berking C, Heppt M Conference contribution B-cells in psoriasis? (2021) Banki S, Heusinger J, Herter-Kermann T, Sticherling M Conference contribution Expert Consensus on practice-relevant Aspects during the Treatment of chronic Urticaria (2021) Bauer A, Dickel H, Jakob T, Kleinheinz A, Lippert U, Metz M, Schliemann S, et al. Journal article Expert consensus on practical aspects in the treatment of chronic urticaria (2021) Bauer A, Dickel H, Jakob T, Kleinheinz A, Lippert U, Metz M, Schliemann S, et al. Journal article, Review article The IKZF1–IRF4/IRF5 axis controls polarization of myeloma-associated macrophages (2021) Mougiakakos D, Bach C, Böttcher M, Beier F, Röhner L, Stoll A, Rehli M, et al. Journal article